Journal
HUMAN REPRODUCTION
Volume 22, Issue 5, Pages 1450-1456Publisher
OXFORD UNIV PRESS
DOI: 10.1093/humrep/del503
Keywords
cyclooxygenase; heavy menstruation; menorrhagia; prostaglandin receptors
Categories
Funding
- MRC [MC_U127684438, G0500047] Funding Source: UKRI
- Medical Research Council [G0500047, MC_U127684438] Funding Source: researchfish
- Medical Research Council [U.1276.00.004.00002.01/2(61014), MC_U127684438, G0500047(73331), G0500047] Funding Source: Medline
Ask authors/readers for more resources
BACKGROUND: Although the mechanisms underlying the causes of heavy menstrual blood loss (MBL) remain to be elucidated, prostaglandins have been previously implicated. This study was initiated to elucidate a pattern of expression of the various components of the cyclooxygenase (COX)-prostaglandin signalling pathways present in the endometrium of women with normal and heavy MBLs. METHODS: Endometrial biopsies were collected at different stages of the menstrual cycle from women who underwent measurement of MBL. Tissue was divided for either examination of gene expression by quantitative RT-PCR analysis or in vitro culture experimentation. RESULTS: Analysis of gene expression demonstrated a significant elevation in expression of COX-1 and COX-2 mRNA in endometrium obtained from women with heavy MBL when compared with endometrium obtained from women with normal MBL. Tissue culture with PGE(2) stimulation caused a significantly elevated production of cyclic AMP (cAMP) by endometrium of women with heavy MBL when compared with normal MBL. Expression of phosphodiesterase 4B, an enzyme involved in cAMP breakdown, was reduced in these same endometrial samples obtained from women with heavy MBL. CONCLUSIONS: These data identify the E series prostaglandin receptors and their signalling pathways as potential therapeutic targets in the treatment of heavy menstruation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available